PTGX FDA approves MIMRYLO for PV
PTGX says the FDA approved MIMRYLO for PV, positioning it as erythrocytosis-specific therapy.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.